Web-based Delivery of Effective Treatment for Growth in Cystic Fibrosis (Be In Charge)
Primary Purpose
Cystic Fibrosis
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Web Intervention
Sponsored by
About this trial
This is an interventional treatment trial for Cystic Fibrosis focused on measuring Cystic Fibrosis, Behavioral Intervention, Children
Eligibility Criteria
Inclusion Criteria:
- Clinical diagnosis of Cystic Fibrosis
- Ages 4 to 9 year
- below the 50th percentile for body mass index for age and gender
- and their parents
Exclusion Criteria:
- medical condition that would affect diet or growth (e.g., type 1 diabetes mellitus)
- significant developmental delays
- a sputum culture positive for Burkholderia cepacia
- a forced expiratory volume in the first second of expiration (FEV1) of less than 40%
- receiving enteral or parenteral nutrition.
Sites / Locations
- Cincinnati Children's Hospital Medical Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Web Intervention
Usual Care
Arm Description
BeInCharge has two components: an electronic diet tracker and a 7 session intervention. The 7 treatment sessions are designed to be completed over a 7 to 10 week period. Each treatment module includes both a nutrition education and child behavior management component. Treatment sessions should be completed every 7 to 10 days, while the electronic diet tracker requires daily input.
Participants will receive usual care and be assessed at baseline and week 10 for study outcomes.
Outcomes
Primary Outcome Measures
Change in Average Daily Caloric Intake
Change in average daily caloric intake at baseline and 10 weeks.
Secondary Outcome Measures
Change in Weight
Change in weight from baseline to 10 weeks
Full Information
NCT ID
NCT01686672
First Posted
September 13, 2012
Last Updated
October 17, 2014
Sponsor
Children's Hospital Medical Center, Cincinnati
1. Study Identification
Unique Protocol Identification Number
NCT01686672
Brief Title
Web-based Delivery of Effective Treatment for Growth in Cystic Fibrosis
Acronym
Be In Charge
Official Title
Web-based Delivery of Effective Treatment for Growth in Cystic Fibrosis
Study Type
Interventional
2. Study Status
Record Verification Date
October 2014
Overall Recruitment Status
Completed
Study Start Date
October 2012 (undefined)
Primary Completion Date
September 2013 (Actual)
Study Completion Date
October 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Children's Hospital Medical Center, Cincinnati
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study will demonstrate feasibility and collect pilot data via a pilot randomized trial of 20 participants on the effectiveness of a web-based delivery system of behavioral plus nutrition intervention for parents of children with Cystic Fibrosis (CF) ages 4 to 9 years of age that has been found to be efficacious in face to face delivery.
Detailed Description
Optimizing nutritional status and growth improves health outcomes and survival in children with cystic fibrosis (CF). Better pulmonary function, as measured by forced expiratory rate in 1 second (FEV1), is associated with body mass index (BMI) above the 50th percentile for age and gender for children with CF1. Evidence based practice guidelines recommend that nutritional treatment for children with CF ages 2 to 20 years should aim to achieve and maintain a BMI > 50th percentile, however across 117 CF centers in the United States 57% of girls and 56% of boys failed to meet this recommendation1. The investigators have developed a highly effective behavioral plus nutrition intervention (BE IN CHARGE) and demonstrated its efficacy when delivered face-to-face to produce weight gain and its superiority over nutrition education alone. Although endorsed by the CF Foundation as an evidence-based treatment, it is not available to most CF Centers or families due to lack of trained personnel, cost, and distance issues. With funding from the CF Foundation the investigators developed a web-based delivery system of their efficacious behavioral plus nutrition intervention for parents of children with CF ages 4 to 9 years of age. Using a Place Outcomes Award the investigators have conducted beta testing of the web-intervention and made appropriate modifications. The current study represents the next steps in refining and testing our web-based intervention. This study will demonstrate feasibility and collect pilot data on the effectiveness of the intervention in a pilot randomized trial of 20 treatment naïve participants.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cystic Fibrosis
Keywords
Cystic Fibrosis, Behavioral Intervention, Children
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
12 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Web Intervention
Arm Type
Experimental
Arm Description
BeInCharge has two components: an electronic diet tracker and a 7 session intervention. The 7 treatment sessions are designed to be completed over a 7 to 10 week period. Each treatment module includes both a nutrition education and child behavior management component. Treatment sessions should be completed every 7 to 10 days, while the electronic diet tracker requires daily input.
Arm Title
Usual Care
Arm Type
No Intervention
Arm Description
Participants will receive usual care and be assessed at baseline and week 10 for study outcomes.
Intervention Type
Behavioral
Intervention Name(s)
Web Intervention
Other Intervention Name(s)
Be In Charge
Intervention Description
Behavioral
Primary Outcome Measure Information:
Title
Change in Average Daily Caloric Intake
Description
Change in average daily caloric intake at baseline and 10 weeks.
Time Frame
Baseline and 10 weeks
Secondary Outcome Measure Information:
Title
Change in Weight
Description
Change in weight from baseline to 10 weeks
Time Frame
Baseline and 10 weeks
Other Pre-specified Outcome Measures:
Title
Use of web-based intervention
Description
Ongoing use of web-intervention collected electronically via the web to include sign on, duration of time on web, page views, and completion of activities on the web-site
Time Frame
10 weeks
Title
Treatment Satisfaction
Description
Assessment of participant's satisfaction with the intervention and web-site
Time Frame
10 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
4 Years
Maximum Age & Unit of Time
9 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Clinical diagnosis of Cystic Fibrosis
Ages 4 to 9 year
below the 50th percentile for body mass index for age and gender
and their parents
Exclusion Criteria:
medical condition that would affect diet or growth (e.g., type 1 diabetes mellitus)
significant developmental delays
a sputum culture positive for Burkholderia cepacia
a forced expiratory volume in the first second of expiration (FEV1) of less than 40%
receiving enteral or parenteral nutrition.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lori Stark, Ph.D.
Organizational Affiliation
Children's Hospital Medical Center, Cincinnati
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cincinnati Children's Hospital Medical Center
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45239
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Web-based Delivery of Effective Treatment for Growth in Cystic Fibrosis
We'll reach out to this number within 24 hrs